All Columns articles – Page 2
-
OpinionChina’s drug development charge
Reforms and state support have fuelled domestic and foreign investment in pharmaceutical
-
OpinionChemistry ‘deserts’ threaten to push poorer undergraduates out
Course and departmental closures in the UK are creating ‘cold spots’, leaving students high and dry
-
-
BusinessWill HIV prevention get where it’s needed?
Gilead and its partners’ efforts to distribute generic lenacapavir could be derailed by cuts in international aid budgets
-
OpinionGetting good at human tasks
’What do you mean you had to lock the NMR with an oscilloscope and shim the magnet by hand?’
-
OpinionChemistry's capital C
From refinery scale to a nanosecond existence, carbon is everywhere – in life as well as chemistry
-
OpinionCritical metals supply strained
Conflict - both military and political - is having profound effects on supplies of a wide range of materials
-
OpinionThe future of oil refining in the UK
Can plants adapt to be compatible with a lower-carbon environment?
-
OpinionNon-hallucinogenic psychedelics
Chemical insights and advances are contributing to a new therapeutic avenue for mental health conditions
-
OpinionSafety is everyone’s responsibility
Maintaining culture and investment is key, especially in the absence of incidents
-
OpinionIgnoring women’s health shouldn’t be an option
Developing therapies for conditions that predominantly affect women is a neglected, but enormous, opportunity
-
OpinionWomen are not just another confounding factor in drug development
Ignoring physiological differences between the sexes is indefensible
-
OpinionRebuilding pharma supply chains
Multinationals are promising huge US investments, but it’s not all because of Trump’s policies
-
OpinionIran port explosion highlights issues of shipping hazardous chemicals
Intersecting regulations and jurisdictions mean rules can be accidentally or deliberately overlooked
-
OpinionIn search of truth and rules
To codify and predict ever more complex phenomena is one of science’s great drivers
-
OpinionQuality research under threat as budgets are being squeezed
Researchers are once again being asked to turn less into more
-
OpinionGiving companies room to grow
Can shopping centres and offices become urban lab spaces for innovative companies to grow and scale-up?
-
OpinionPolymorphs matter – especially when they might disappear
Disappearing polymorphs offer a fascinating example of the dark arts of crystallisation
-
BusinessAcceptable levels of (epi)genetic engineering
Amplifying or silencing genes may be preferable to permanently changing genetic code
-
OpinionTrump’s tariff stand-off
Piling cost and complexity to stretched global supply chains will hit industries hard